Telomitantan 80 mg (Telmisartan)

Adult dose

Essential hypertension Adults: Administer orally 40 mg once daily as Telmisartan, taken with water, regardless of meals. In some patients, 20 mg once daily may also be effective. If necessary, the dose can be increased up to 80 mg once daily, and maximum blood pressure-lowering effects appear 4 to 8 weeks after the dose increase. Reduction of cardiovascular disease risk Adults: It is recommended to administer 80 mg orally once daily with water, regardless of meals.

This medication can cause serious injury to the fetus and newborn, particularly during pregnancy, and should be discontinued immediately if pregnancy is confirmed. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients with severely impaired liver function or problems with bile excretion should not use this medication. Patients with hereditary angioedema or a history of angioedema should also avoid this medication. In diabetic patients with severely decreased kidney function, the combination of this medication with certain drugs may pose risks, so caution is advised. Elderly patients, patients with hyperkalemia, and those with mild liver impairment should also use this medication with caution. Patients with heart disease or cerebrovascular disease should be careful to avoid excessively low blood pressure. Patients with ulcers or inflammation in the stomach may be at risk of gastrointestinal bleeding, so caution is necessary. Patients with problems in renal blood vessels should be cautious, as kidney function may worsen when taking this medication. This medication lowers blood pressure, which may result in hypotension or fainting, so patient condition should be closely monitored. There is a risk of increased potassium levels in the blood, so regular blood tests are important. This medication may interact with other antihypertensive drugs, so it should be taken after consulting with a physician. Particular caution is needed when used in conjunction with lithium, certain diuretics, and non-steroidal anti-inflammatory drugs (NSAIDs). Patients should be cautious when driving or operating machinery due to the risk of dizziness or fainting. In case of overdose, symptoms may include hypotension, cardiac arrhythmia, and worsening kidney function; seek medical assistance immediately. This medication is not recommended for children and adolescents under 18 years of age, as its safety and effectiveness have not been established. Keep this medication out of reach of children and only use after opening the sealed package.

Serious side effects

Urticaria, severe swelling (including angioedema), chest tightness, difficulty breathing, cold sweats, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, sores in the mouth/eyes, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, breath problems, jaundice, severe malaise, liver abnormalities (jaundice)

Mild side effects

• Upper respiratory tract infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help maintain the efficacy and safety of the medication.

Appearance

White oval tablets

Package unit

30 tablets/box [10 tablets/Alu-Alu x 3], 30 tablets/bottle